Epilepsy treatment gap linked more to perceptions than disease burden in rural India

What was studied

Researchers surveyed 130,509 people door to door across 96 villages in rural Gujarat, India. Neurologists diagnosed 393 people with active epilepsy, and treatment information was available for 371 of them.

The study examined who had never started anti-seizure medication and who had stopped it after starting. Researchers assessed clinical characteristics, healthcare use, treatment perceptions, and quality of life. They also offered free medication to 94 untreated people and tracked whether they remained in care.

What they found

Among the 371 people with treatment information, 247 (66.6%) had a treatment gap. This included 127 (34.2%) who had never received anti-seizure medication and 120 (32.3%) who had stopped it after starting.

Lack of awareness and a low perceived need for treatment accounted for 56% of reported reasons for never starting medication. Perceived cure was the leading reason for stopping, accounting for 35%. Financial and access barriers accounted for 19% of reported reasons.

After statistical adjustment, lack of awareness about medication side effects, disengagement from healthcare, faith-healing beliefs, and preference for non-specialist care were independently associated with never starting treatment. People who had never started treatment had the poorest quality of life. Among the 94 untreated people offered free medication, 32 (34.0%) remained in care at three months and 17 (18.1%) at one year.

Limits of the evidence

This observational study identified associations but cannot establish that particular beliefs or healthcare patterns caused the treatment gaps. The findings came from one rural region of India and may not apply to urban areas or settings with different healthcare systems or cultures. Recorded reasons and perceptions may also be affected by how participants understood and reported them.

The free-medication intervention included 94 people, and the abstract does not describe a comparison group. It also does not report whether the intervention reduced seizures or improved quality of life.

For families and caregivers

The findings suggest that providing medication at no cost may not be enough by itself to keep people engaged in epilepsy care. Clear discussions about the need for treatment, medication side effects, and appropriate follow-up may be important. The study also indicates that never starting medication and stopping it later often have different reported reasons and may require different approaches.

What to watch next

Studies in other settings and controlled programs combining medication access, education, specialist involvement, and follow-up could help determine which approaches improve treatment initiation and long-term engagement.

Terms in this summary

Active epilepsy

Epilepsy diagnosed as active by neurologists using standard definitions.

Treatment gap

In this study, not receiving anti-seizure medication because it was never started or was discontinued after initiation.

Primary treatment gap

Never having received anti-seizure medication.

Secondary treatment gap

Discontinuing anti-seizure medication after starting it.

Anti-seizure medication (ASM)

Medicine used to prevent or reduce epileptic seizures.

Multivariable logistic regression

A statistical method used to examine which factors are associated with an outcome while accounting for several other measured factors.

Independent predictor

A factor that remained statistically associated with an outcome after other measured factors were considered.